{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:47Z","timestamp":1789384487799,"version":"build-2803163510"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We evaluated the in vitro and in vivo potencies of a new lipid nanosphere that incorporates amphotericin B (AmB), NS-718, against\n            <jats:italic>Aspergillus fumigatus<\/jats:italic>\n            . The in vitro activity of NS-718 (the MIC at which 90% of strains are inhibited [MIC\n            <jats:sub>90<\/jats:sub>\n            ], 0.25 \u03bcg\/ml) against 18 isolates of\n            <jats:italic>A. fumigatus<\/jats:italic>\n            was similar to that of deoxycholate AmB (D-AmB; Fungizone; MIC\n            <jats:sub>90<\/jats:sub>\n            , 0.25 \u03bcg\/ml), but NS-718 was more potent than liposomal AmB (L-AmB; AmBisome; MIC\n            <jats:sub>90<\/jats:sub>\n            , 1.0 \u03bcg\/ml). The in vivo efficacy of NS-718 in a rat model of invasive pulmonary aspergillosis was compared with those of D-AmB and L-AmB. A low dose (1 mg\/kg of body weight) of L-AmB was ineffective (survival rate, 0%), although equivalent doses of D-AmB and NS-718 were more effective (survival rate, 17%). However, a higher dose of NS-718 (3 mg\/kg) was more effective (survival rate, 100%) than equivalent doses of D-AmB and L-AmB (survival rate, 0%). To explain these differences, pharmacokinetic studies showed higher concentrations of AmB in the plasma of rats treated with NS-718 than in the plasma of those treated with D-AmB. Our results suggest that NS-718, a new preparation of AmB, is a promising antifungal agent with activity against pulmonary aspergillosis.\n          <\/jats:p>","DOI":"10.1128\/aac.43.3.471","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:34:19Z","timestamp":1539045259000},"page":"471-475","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere Incorporating Amphotericin B, against\n            <i>Aspergillus fumigatus<\/i>"],"prefix":"10.1128","volume":"43","author":[{"given":"Takakazu","family":"Otsubo","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigefumi","family":"Maesaki","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ashraf","family":"Hossain","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Tomono","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Tashiro","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Seki","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Research Laboratories, Nippon Shinyaku Co., Ltd., 14 Nishinosho-Monguchicho, Kisshoin, Minami-ku, Kyoto, 601-8550,2 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Tomii","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Research Laboratories, Nippon Shinyaku Co., Ltd., 14 Nishinosho-Monguchicho, Kisshoin, Minami-ku, Kyoto, 601-8550,2 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Sonoke","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Research Laboratories, Nippon Shinyaku Co., Ltd., 14 Nishinosho-Monguchicho, Kisshoin, Minami-ku, Kyoto, 601-8550,2 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->The Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.4.615"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(97)00194-4","article-title":"Poly (\u025b-caprolacton) nanoparticles as an alternative way to reduce amphotericin B toxicity.","volume":"158","author":"Espuelas M. S.","year":"1997","unstructured":"Espuelas M. S. Legrand P. Irache J. M. Gamazo C. Orecchioni A. M. Devissaguet J. P. Ygartua P. Poly (\u025b-caprolacton) nanoparticles as an alternative way to reduce amphotericin B toxicity. Int. J. Pharm. 158 1997 19 27","journal-title":"Int. J. Pharm."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.6.1208"},{"key":"e_1_3_2_5_2","unstructured":"Fukui\n              H.\n              Koike\n              T.\n              Saheki\n              A.\n              Sonoke\n              S.\n              Yoshikawa\n              H.\n              Sasaki\n              H.\n              Tomii\n              Y.\n              Seki\n              J.\n          A novel antifungal drug delivery system: lipid nanosphere incorporating amphotericin B (LNS-AmB) abstr. 5026\n          Proceedings of the 23rd International Symposium on Controlled Release of Bioactive Materials\n          1996\n          655"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.4.584"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-4453(94)95956-0","article-title":"Liposomal amphotericin B, AmBisome.","volume":"28","author":"Hay R. J.","year":"1994","unstructured":"Hay R. J. Liposomal amphotericin B, AmBisome. J. Infect. 28 (Suppl. I) 1994 35 43","journal-title":"J. Infect."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1722"},{"key":"e_1_3_2_9_2","unstructured":"Kohno\n              S.\n              Otsubo\n              T.\n              Hara\n              K.\n              Tomii\n              Y.\n              Seki\n              J.\n          A new antifungal drug delivery system lipid nanosphere encapsulating amphotericin B (LNS-AmB) its evaluation in the rat model of invasive pulmonary aspergillosis abstr. 109\n          Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy.\n          1995\n          131\n          American Society for Microbiology\n          Washington D.C"},{"key":"e_1_3_2_10_2","unstructured":"Kohno\n              S.\n              Hara\n              K.\n              Murahashi\n              N.\n              Watanabe\n              T.\n          Amphotericin B incorporated in lipid emulsion (lipid microsphere)\n          Recent progress in antifungal chemotherapy.\n              Yamaguchi\n              H.\n              Kobayashi\n              G. S.\n              Takahashi\n              H.\n          1991\n          333\n          339\n          Marcel Dekker Inc.\n          New York N.Y"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/088391158800300204","article-title":"Polysaccharide-coated liposomes with antimicrobial agents against intracytoplasmic pathogens and fungi.","volume":"3","author":"Kohno S.","year":"1988","unstructured":"Kohno S. Miyazaki T. Yamaguchi K. Tanaka H. Hayashi T. Hirota M. Saito A. Hara K. Sato T. Sunamoto J. Polysaccharide-coated liposomes with antimicrobial agents against intracytoplasmic pathogens and fungi. J. Bioact. Compat. Polym. 3 1988 137 147","journal-title":"J. Bioact. Compat. Polym."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.11.2518"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.8.1999-2005.1992"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01104273"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.12.2762"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-3278(91)90058-D","article-title":"Lipo-prostaglandin preparations.","volume":"42","author":"Mizushima Y.","year":"1991","unstructured":"Mizushima Y. Lipo-prostaglandin preparations. Prostaglandins Leukot. Essent. Fatty Acids 42 1991 1 6","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.2042-7158.1982.tb04678.x","article-title":"Use of a lipid emulsion as a novel carrier for corticosteroids.","volume":"34","author":"Mizushima Y.","year":"1982","unstructured":"Mizushima Y. Hamano T. Yokoyama K. Use of a lipid emulsion as a novel carrier for corticosteroids. J. Pharm. Pharmacol. 34 1982 49 50","journal-title":"J. Pharm. Pharmacol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.2042-7158.1983.tb02969.x","article-title":"Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere.","volume":"35","author":"Mizushima Y.","year":"1983","unstructured":"Mizushima Y. Wada Y. Etoh Y. Watanabe K. Anti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere. J. Pharm. Pharmacol. 35 1983 398 399","journal-title":"J. Pharm. Pharmacol."},{"key":"e_1_3_2_19_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A.\n          1997\n          National Committee for Clinical Laboratory Standards\n          Wayne Pa"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/infdis\/169.5.1057","article-title":"Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of localized murine candidiasis.","volume":"169","author":"Pahls S.","year":"1994","unstructured":"Pahls S. Schaffner A. Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of localized murine candidiasis. J. Infect. Dis. 169 1994 1057 1061","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0168-3659(94)90212-7","article-title":"Lipid nanosphere (LNS), a protein free analogue of lipoproteins, as a novel drug carrier for parenteral administration.","volume":"28","author":"Seki J.","year":"1994","unstructured":"Seki J. Sasaki H. Doi M. Yoshikawa H. Takahashi Y. Yamane S. Fukui H. Sonoke S. Yamamoto H. Hirose M. Ezure Y. Ando T. Ushimaru K. Sugiyama M. Lipid nanosphere (LNS), a protein free analogue of lipoproteins, as a novel drug carrier for parenteral administration. J. Controlled Release 28 1994 352 353","journal-title":"J. Controlled Release"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/32.5.723","article-title":"Efficacies of amphotericin B-deoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leukopenic mice.","volume":"32","author":"Van Etten E. W. M.","year":"1993","unstructured":"Van Etten E. W. M. Van den Heuvel-de Groot C. Bakker-Woudenberg I. A. J. M. Efficacies of amphotericin B-deoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leukopenic mice. J. Antimicrob. Chemother. 32 1993 723 739","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.3.471","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.3.471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:13:19Z","timestamp":1645459999000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.3.471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["10.1128\/AAC.43.3.471"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.3.471","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]},"assertion":[{"value":"1998-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-12-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}